CoChat

Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure

Scheen, André J. · 2019 · Current Cardiology Reports

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Abstract

Purpose of the review Hyperactivity of sympathetic nervous system (SNS) plays a role in the development of arterial hypertension and heart failure, two co-morbidities frequently associated with type 2 diabetes (T2DM). This review aims at analyzing the effects of sodium-glucose cotransporter type 2 inhibitors (SGLT2is) on blood pressure and more especially on SNS activity in patients with T2DM.Recent findings By enhancing glucosuria, natriuresis, and osmotic diuresis, SGLT2is improve glucose control, promote weight loss, lower arterial blood pressure, and reduce the risk of major cardiovascular events and hospitalization for heart failure. No rise of heart rate is detected despite reductions in blood pressure and plasma volume, which may suggest a dampening of SNS activity. Indeed, increasing experimental and clinical data demonstrated a reduction in SNS activity, including in key target organs such as the heart and the kidneys. Of potential major interest, a better understanding of the mechanisms linking SGLT2 and SNS deserves further investigation.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11886-019-1165-1

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 101 references

Cited by

See all 127

Metadata

Authors
Scheen, A. J.
Affiliations
University of Liège (BE)
Corresponding author
Scheen, André J.
Venue
Current Cardiology Reports
Published
2019-06-21
Volume
21
Issue
8
Pages
70-70
ISSN
  • 1523-3782 (ISSN-L)
  • 1534-3170
OpenAlex
W2952211646
Cited by
122
References
101
Citations by year
2026: 5 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 39 · 2021: 23 · 2020: 14 · 2019: 2
FWCI
3.00
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Current Cardiology Reports (publishedVersion)
  • PubMed (publishedVersion)
  • ORBi (University of Liège) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
SGLT2 inhibitors, sympathetic nervous system, blood pressure, hypertension, type 2 diabetes, heart failure, glycosuria, sodium excretion, osmotic diuresis, heart rate, cardiovascular events, renal sympathetic nerve activity
MeSH terms
Sodium-Glucose Transporter 2 Inhibitors, Blood Pressure, Diabetes Mellitus, Type 2, Humans, Hypertension, Hypoglycemic Agents, Sympathetic Nervous System, Treatment Outcome, Sodium-Glucose Transporter 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure. https://app.cochat.ai/papers/10.1007/s11886-019-1165-1
The paper
Scheen, A. J. (2019). Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure. Current Cardiology Reports. https://doi.org/10.1007/s11886-019-1165-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.